Illumina Creates New, $100M Venture Fund

San Diego-based life sciences equipment maker Illumina has created a new, $100M venture capital fund, the company said Thursday afternoon, which will focus on investments in early stage companies that are pioneering new applications of nucleic acid sequencing, developing products that will expand the genomics ecosystem, and utilizing genomics to improve human health. According to Illumina, it will commit $100M over 10 years to the new fund, to be run by new venture capital firm Illumina Ventures. The new investment firm will be led by Nicholas NAclerio, Ph.D., the former Senior Vice President, Corporate and Venture Development at Illumina.